investig
transmiss
coronaviru
symptomat
asymptomat
patient
use
ningbo
data
indepth
comprehens
statist
analysi
conclud
differ
transmiss
rate
coronaviru
symptomat
asymptomat
patient
consist
origin
find
chen
et
al
sinc
outbreak
novel
coronaviru
diseas
decemb
coronaviru
spread
world
unpreced
rate
april
countri
affect
total
close
one
million
confirm
case
death
declar
intern
public
health
emerg
world
health
organ
incub
period
percentag
coronaviru
carrier
may
symptom
minim
symptom
thu
often
go
undetect
covert
coronaviru
carrier
may
even
awar
infect
howev
would
confirm
posit
case
test
use
revers
transcriptas
polymeras
chain
reaction
rtpcr
percentag
asymptomat
carrier
larg
transmiss
coronaviru
high
symptomat
case
would
pose
great
threat
public
therefor
critic
determin
percentag
transmiss
asymptomat
coronaviru
carrier
popul
report
viral
load
detect
asymptomat
patient
similar
symptomat
patient
suggest
potenti
transmiss
asymptomat
patient
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ningbo
china
transmiss
rate
coronaviru
symptomat
asymptomat
case
estim
transmiss
rate
symptomat
asymptomat
patient
respect
chisquar
test
yield
pvalu
indic
statist
signific
differ
two
transmiss
rate
investig
transmiss
rate
differ
relationship
differ
type
contact
infect
patient
includ
symptomat
asymptomat
case
conclud
differ
transmiss
rate
statist
signific
across
differ
relationship
type
contact
respect
closer
contact
infect
patient
higher
chanc
infect
howev
origin
statist
analysi
chisquar
test
unduli
use
count
cell
conting
tabl
rather
small
even
zero
violat
assumpt
chisquar
test
thu
cast
doubt
valid
hypothesi
test
moreov
compar
transmiss
rate
symptomat
asymptomat
case
chen
et
al
includ
case
associ
superspread
mainli
transmit
diseas
aircondit
bu
buddhism
activ
gather
howev
may
reduc
gener
find
superspread
regard
outlier
remov
primari
analysi
januari
march
symptomat
case
asymptomat
case
ningbo
data
infect
case
result
close
contact
among
exposur
caus
symptomat
case
asymptomat
case
averag
number
close
contact
symptomat
case
asymptomat
case
differ
statist
signific
pvalu
permut
test
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
describ
algorithm
larger
number
close
contact
symptomat
case
may
due
medic
attent
receiv
confirm
diagnosi
allow
small
cell
count
includ
zero
conting
tabl
fisher
exact
test
use
investig
differ
transmiss
rate
symptomat
asymptomat
patient
consid
two
scenario
one
combin
number
symptomat
asymptomat
case
total
number
infect
patient
lead
tabl
separ
lead
tabl
shown
top
panel
tabl
result
summar
tabl
conclud
signific
differ
transmiss
rate
symptomat
asymptomat
case
either
includ
exclud
case
associ
superspread
howev
test
exclud
case
associ
superspread
yield
larger
pvalu
combin
number
symptomat
asymptomat
case
separ
result
evid
data
rule
transmiss
asymptot
carrier
comparison
symptomat
case
odd
ratio
estim
transmiss
rate
differ
symptomat
asymptomat
case
well
correspond
confid
interv
present
bottom
panel
tabl
odd
transmit
coronaviru
healthi
individu
symptomat
patient
time
asymptomat
patient
howev
statist
signific
confid
interv
cover
one
furthermor
confid
interv
differ
transmiss
rate
cover
zero
conclud
differ
transmiss
coronaviru
close
contact
symptomat
asymptomat
case
consist
find
use
fisher
exact
test
transmiss
rate
differ
relationship
infect
case
significantli
differ
pvalu
whether
combin
symptomat
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
asymptomat
case
regard
differ
type
contact
transmiss
rate
also
significantli
differ
pvalu
expect
close
contact
infect
case
higher
likelihood
contract
coronaviru
summari
provid
indepth
analysi
ningbo
data
examin
differ
transmiss
coronaviru
symptomat
asymptomat
patient
adopt
appropri
statist
method
fisher
exact
test
requir
assumpt
cell
count
conting
tabl
provid
odd
ratio
estim
transmiss
rate
well
correspond
confid
interv
conclus
remain
statist
signific
differ
transmiss
coronaviru
symptomat
asymptomat
patient
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
